Randox Toxicology’s universally available patented Biochip Array Technology boasts cutting-edge multiplex testing capabilities, providing rapid and accurate drug detection from a single sample. Based on ELISA principles, the biochip is a solid-state device with discrete test sites onto which antibodies specific to different drug compounds are immobilised and stabilised. Competitive chemiluminescent immunoassays are then employed, offering a highly sensitive screen.
Offering excellent cross-reactivity and unrivalled limits of detection over a range of routine and novel assays Biochip Array Technology is the world's first multiplex screening technology. Designed to work across multiple matrices such as urine, blood, and oral fluid its intra and inter assay precision is typically <10% giving excellent correlation with confirmatory methods.
Don’t miss Chetan Soni from Omega Laboratories presentation:
“Validation of Multiplex Array Platform for Drugs of Abuse Hair Screening”
at this year’s Midwest Association for Toxicology and Therapeutic Drug Monitoring (MATT), 12th – 13th April 2018.
Drop by our stand at MATT 2018 to speak with Pankaj Sinha, Michael Hagstrom and Matthew Swanson about our revolutionary Biochip Array Technology, ELISA kits and our unrivalled drugs of abuse test menu!